Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment

NCT00087958 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi